4.6 Article

DNA-Based Smart Reagent for Detecting Alzheimer's Associated MicroRNAs

期刊

ACS SENSORS
卷 6, 期 9, 页码 3176-3181

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acssensors.1c01567

关键词

DNA nanoswitch; DNA nanotechnology; Alzheimer's disease; microRNAs; neurological disorders; diagnostics; biomarkers

向作者/读者索取更多资源

Alzheimer's disease is a common neurodegenerative disorder, and microRNAs have emerged as potential regulators and biomarkers for the disease. A new technology, miRacles assay, allows for single-step detection of AD-related microRNAs without the need for amplification or labeling. Through screening 56 AD-related microRNAs, four were found to have detectable differences between RNA extracts from healthy and AD brain samples, showing promise for clinical use as diagnostic tools.
Alzheimer's disease (AD) is the most common neurodegenerative disorder, with significant research efforts devoted to identifying new biomarkers for clinical diagnosis and treatment. MicroRNAs have emerged as likely disease regulators and biomarkers for AD, now implicated as having roles in several biological processes related to progression of the disease. In this work, we use the miRacles assay (microRNA activated conditional looping of engineered switches) for single-step detection of AD-related microRNAs. The technology is based on conformationally responsive DNA nano-switches that loop upon recognition of a target microRNA and report their on/off status through an electrophoretic readout. Unlike many methods, our approach directly detects native microRNAs without amplification or labeling, eliminating the need for expensive enzymes, reagents, and equipment. For known AD-related microRNA miR-107, we demonstrated sensitivity of similar to 8 fM, specificity among four similar microRNAs of the same family, and simultaneous multiplexed detection of those four microRNA targets. Toward clinical use, we screened 56 AD-related microRNAs and found four that showed detectable differences between total RNA extracts derived from human healthy and AD brain samples. In the context of AD, this smart reagent could facilitate biomarker discovery, accelerate efforts to understand the role of microRNAs in AD, and have clinical potential as a diagnostic or monitoring tool for validated biomarkers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据